Nymox Pharmaceutical Corp (NASDAQ:NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Recs

0
Player Avatar GershwinStephen (< 20) Submitted: 1/30/2008 5:33:55 PM : Outperform Start Price: $5.07 NYMX Score: +47.09

acquisiton,

Featured Broker Partners


Advertisement